| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | +568.7% |
| R&D Expense | $20.0M | -54.9% |
| SG&A Expense | $14.1M | -4.1% |
| Operating Income | -$33.0M | +44.3% |
| Pre-tax Income | -$29.4M | +50.4% |
| Income Tax | $4K | -32.2% |
| Net Income | -$29.4M | +50.4% |
| EPS (Basic) | -$1.52 | +82.1% |
| EPS (Diluted) | -$1.52 |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $119.2M | +616.2% |
| Current Assets | $120.7M | +589.3% |
| Total Assets | $123.7M | +486.3% |
| Current Liabilities | $5.1M | +12.2% |
| Total Liabilities | $9.4M | +4.0% |
| Stockholders' Equity | $114.3M | +846.1% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.8M | +48.1% |
| Investing Cash Flow | -$61K | +91.8% |
| Financing Cash Flow | $128.4M | — |
| +82.1% |